In conclusion, significant biomarkers of inflammation (TNFα, IL-6, hsCRP, and haptoglobin) and endothelial dysfunction (sICAM-1 and sVCAM-1) are present in young patients with diabetes, obesity, and dyslipidemia. This evidence concerns the gene HP and metabolic syndrome.